Lidocaine and ketamine for severe cancer pain not helped by opioids
Part of Cancer, Mental health, Pain clinical trials.
This trial tests if adding lidocaine and ketamine to your current pain medicines can better control severe cancer-related pain that opioids alone haven't helped.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic cancer-related pain that is moderate to severe (at least 4 on a 0–10 pain scale)
- You are already taking strong opioid pain medicine (at least 60 mg of morphine per day or the most you can tolerate)
- If your pain has a nerve-related (neuropathic) component, you have tried at least one nerve pain medicine (like amitriptyline, duloxetine, gabapentin, pregabalin, or venlafaxine)
- You do not have serious liver, kidney, heart, or thyroid problems, porphyria, or a history of psychosis, schizophrenia, or substance abuse
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving two pain-relieving medicines, ketamine and lidocaine, through an IV can help adults with chronic migraine that hasn't improved with other treatments. The goal is to see if this treatment reduces migraine pain and improves daily life.
This trial studies whether a lidocaine infusion can help manage pain in patients with cancer-related bowel blockages. It aims to see if it can improve pain scores and reduce the need for other pain medications.
This trial tests whether two medicines, esketamine and lidocaine, can reduce long-term pain after liver surgery and possibly improve survival. It is for people who are having a planned liver removal (hepatectomy).
This trial tests whether giving a medicine called lidocaine through a vein during emergency abdominal surgery can reduce long-term pain after the operation. Lidocaine is a common numbing medicine, and this study aims to see if it helps prevent chronic pain that some people experience after surgery.
This trial tests whether adding non-opioid pain relievers (like dipyrone or ibuprofen) to your usual opioid pain medication can better control cancer pain. It aims to see if the combination is more effective and safe.
This early-phase study tests whether gabapentin and a ketamine nasal spray can help prevent or lessen short-term and long-term pain from locally advanced head and neck cancer. It may help by changing how the nervous system responds to pain during and after radiation and chemoradiation.
Hear when a new Opioid-Refractory Chronic Cancer-Related Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.